Trosovavilp alfa

曲索韦普α

Report date: 2026/05/02 20:00:18

Base Information

Drug NameTrosovavilp alfa
Drug Alias NameChikungunya-virus-vaccine-VRC (Paxvax)明矾佐剂化的基孔肯雅病毒样颗粒疫苗 (Paxvax)Recombinant Chikungunya Vaccine (Paxvax)Alum-adjuvanted chikungunya virus-like particle vaccine (Paxvax)Chikungunya virus virus-like particle vaccine (Paxvax) +[9] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsChikungunya Fever
Global Approved IndicationsChikungunya Fever
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/02/14
Country/TerritoryUnited StatesThailandPuerto Rico +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPaxvax
China Registration ClassN/A

Develop Information

Active CompaniesBiological E LtdBavarian Nordic A/S
Inactive CompaniesEmergent Biosolutions Inc
Active IndicationsChikungunya Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A